Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losmapimod in neuropathic pain from peripheral nerve injury
NCT00969059Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of losmapimod in neuropathic pain, sponsored by GSK. Started Aug 2009; status: completed.
02
Drugs
losmapimod
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00969059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00969059.